Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
about
Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathwayTherapeutic potential of PDE modulation in treating heart diseaseDual Specificity and Novel Structural Folding of Yeast Phosphodiesterase-1 for Hydrolysis of Second Messengers Cyclic Adenosine and Guanosine 3′,5′-MonophosphatePhosphodiesterases and cardiac cGMP: evolving roles and controversiesPriming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafilThe emperor's new clothes: PDE5 and the heartCyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heartConcerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin IICardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.Advances in targeting cyclic nucleotide phosphodiesterasescGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway.Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.Cyclic nucleotide phosphodiesterase 1 and vascular agingCompartmentalization of beta-adrenergic signals in cardiomyocytes.Rare DNA copy number variants in cardiovascular malformations with extracardiac abnormalitiesHigenamine protects ischemia/reperfusion induced cardiac injury and myocyte apoptosis through activation of β2-AR/PI3K/AKT signaling pathway.Vinpocetine attenuates lipid accumulation and atherosclerosis formation.Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G.Luteinizing Hormone Causes Phosphorylation and Activation of the cGMP Phosphodiesterase PDE5 in Rat Ovarian Follicles, Contributing, Together with PDE1 Activity, to the Resumption of MeiosisCyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury.PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction.Interactions of Calcium Fluctuations during Cardiomyocyte Contraction with Real-Time cAMP Dynamics Detected by FRET.PDE1 isozymes, key regulators of pathological vascular remodelingCyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.Therapeutic implications of small interfering RNA in cardiovascular diseases.Phosphodiesterases and cyclic GMP regulation in heart muscle.Compartmentation of cAMP signalling in cardiomyocytes in health and disease.Cell- and molecular-level mechanisms contributing to diastolic dysfunction in HFpEFSmall molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.Generation and phenotypic characterization of Pde1a mutant mice.Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5.Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo.
P2860
Q24616719-684FD5B3-2514-47A3-A43A-C625F46E8B44Q27005761-7DF8FF77-F867-4F18-84C9-8576ECEDCD2EQ27684785-1CF5FD67-B26E-4F27-BC0E-4AFF6FFD5E08Q27692588-2028C627-D9EE-40CF-81DC-732149050624Q28084015-0ABCB38A-8928-4FA2-A4E3-B97DB77D5813Q28543897-5B99819B-CB0F-4BF5-B331-AF7AA1FD0C1DQ28574432-F6E6F403-855D-41F4-8AC0-F5F36DC28350Q33769656-896BD076-FCFA-4667-B931-4F3B8F20D379Q33966155-75C21D34-B09C-46B1-934B-924E1CF29DF8Q34139490-C621A4FA-D2AA-48D9-B82A-DF47EFF3CA39Q34244951-2998F382-B0FA-419C-80AF-CE143444AEE9Q34252901-D2F0DF74-31CC-44D3-9F1E-FDD5D568CC54Q34765802-73B98982-03A0-4535-8FA5-80069661BB94Q34780141-E6DAB408-EEEC-4E8C-AFD9-B66B335C563EQ36080545-8DD2450C-877E-4DAD-87A2-1AC20360D797Q36128551-63E6D5CD-E77B-469E-9BC7-416E3FBD9E10Q36175455-0F877363-65DD-428D-8A8F-78D2BD61E39AQ36384788-EE187EBC-768B-4FAD-9DB3-3DA5263058CCQ36543066-22A4C998-6B14-4CE2-B380-5027218478E0Q36635750-A12AEBE7-B9F3-4066-97DB-05098ADAE92FQ36928884-C3627601-AB7E-4E8C-8B98-6653130886C4Q37075920-9A0A7817-B0CF-46A9-AD52-1B3B983B5895Q37082085-98831539-2A02-4745-85BB-8BE6895EDF71Q37407038-C921B744-675F-499F-9C0B-7B15A632AEFAQ37417757-D48D2130-1708-4C46-8050-094C66299581Q37486049-C8EABB93-1204-4236-8CF1-8E8F9B3F0306Q37941150-72B74204-2151-4141-B353-67B29A0DCFE7Q37947681-18D42208-8CB2-4DFA-A38F-C19B0FCAA794Q38023881-65A3E50B-7448-4CF5-B955-3F627518E26CQ38033089-9D9B00CC-B68C-40B7-A41F-3F0489E0F5DEQ38079253-F2A52F66-7BB8-46FD-BD3D-D66F9755CF48Q38441801-90940597-E6EA-4B56-BF88-796210B95FE5Q38546917-888B42AA-5823-430B-9AC3-6E73DDC1C703Q38992600-E7B8C0C2-F8E2-448F-B17D-E9FD5DDFB591Q39072124-1D9A4738-665B-4817-B0A4-D50D2EF28653Q40286859-8C7600D9-5384-44E7-A895-7016E452F496Q41153428-0D8FB074-9E4B-4EE9-B8F6-3F02B638F687Q41714003-FD3AB19F-6DC7-4EDC-8CC7-B688C006970DQ42094814-E3C7E4AB-07A9-456A-A7EF-A5C1B2F6E7BBQ42149439-627813DF-655F-43C7-85E2-E3AB48FF82F3
P2860
Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@ast
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@en
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@nl
type
label
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@ast
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@en
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@nl
prefLabel
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@ast
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@en
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@nl
P2093
P2860
P1433
P1476
Role of Ca2+/calmodulin-stimul ...... ing cardiomyocyte hypertrophy.
@en
P2093
Andrew P Wojtovich
Burns C Blaxall
Clint L Miller
David J Nagel
Haodong Xu
Jian-Dong Li
Joseph A Beavo
Jun-ichi Abe
Masayoshi Oikawa
P2860
P304
P356
10.1161/CIRCRESAHA.109.198515
P577
2009-09-24T00:00:00Z